From China’s Ant Group to Sweden’s Klarna, here is the complete list of the world’s top 200 fintech companies.
Schlagwort-Archiv: CNBC
Some crypto assets are securities, Manhattan judge says, laying the groundwork for appeals showdown
A Manhattan federal judge said cryptocurrencies are securities regardless of whom they are offered to, contradicting a prior ruling on cryptoasset Ripple.
Stocks making the biggest moves premarket: Uber, Gap, Caterpillar & more
Despite missing Wall Street’s revenue expectations, shares of Uber rose more than 4% after the ride-hailing giant offered rosy guidance for the third quarter.
State Street is cutting fees on 10 funds worth more than $70 billion combined
The changes impact roughly half of the SPDR Portfolio ETF suite, including funds focused on U.S. stocks, foreign stocks and fixed income.
HSBC net profit more than doubles in the first half, announces $2 billion share buyback
Net profit for the first half stood at $18.1 billion, while revenue for the same period came in at $36.9 billion.
Stocks making the biggest moves after hours: Yum China, Western Digital, ZoomInfo and more
These are the stocks posting the largest moves in extended trading.
Uber shares drop after revenue miss, despite first operating profit
Shares of Uber rose 4% in premarket trading Tuesday after the company reported second-quarter results that missed analysts‘ expectations for revenue but offered rosy guidance.
JetBlue cuts forecast on shift to international travel, end of American Airlines partnership
JetBlue Airways slashed its 2023 outlook and warned of a potential loss in the current quarter.
Pfizer beats on earnings, but revenue misses as Covid product sales plummet
Pfizer is in a transition period as it pivots away from its blockbuster Covid vaccine and drug Paxlovid while the world emerges from the pandemic.
Merck beats on revenue boosted by Keytruda sales, but posts quarterly loss due to Prometheus deal
Shares of Merck are down roughly 4% this year, with a market value of roughly $270 billion, making it the third largest pharmaceutical company based in the U.S.